{"entity":{"type":"insider","cik":"0001916566","url":"/insider/0001916566","json_url":"/insider/0001916566.json","name":"Tourangeau Greg","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2023-05-11","last":"2025-05-09","span_basis":"filed_date"},"name_variants":[{"name":"Tourangeau Greg","source":"filing","n_filings":4,"first_seen":"2023-05-11","last_seen":"2025-05-09"}],"transactions":[{"id":4872925,"accession":"0000950170-25-068038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-068038","line_url":"/filing/0000950170-25-068038#line-1","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001916566","owner_name":"Tourangeau Greg","owner_display_name":"Tourangeau Greg","owner_url":"/insider/0001916566","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":498.0,"shares_display":"498","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":2519.88,"total_display":"2,519.88","total_whole":"2,520","shares_owned_after":14062.0,"shares_owned_after_display":"14,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-08","filed_date":"2025-05-09","scope":"insider"},{"id":2416831,"accession":"0000950170-24-056947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-056947","line_url":"/filing/0000950170-24-056947#line-1","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001916566","owner_name":"Tourangeau Greg","owner_display_name":"Tourangeau Greg","owner_url":"/insider/0001916566","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":236.0,"shares_display":"236","price_per_share":7.76,"price_display":"7.76","price_state":"stated","total_value":1831.36,"total_display":"1,831.36","total_whole":"1,831","shares_owned_after":11571.0,"shares_owned_after_display":"11,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-07","filed_date":"2024-05-09","scope":"insider"},{"id":2587225,"accession":"0000950170-24-028827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-028827","line_url":"/filing/0000950170-24-028827#line-1","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001916566","owner_name":"Tourangeau Greg","owner_display_name":"Tourangeau Greg","owner_url":"/insider/0001916566","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4884.0,"shares_display":"4,884","price_per_share":11.7155,"price_display":"11.72","price_state":"stated","total_value":57218.502,"total_display":"57,218.50","total_whole":"57,219","shares_owned_after":11807.0,"shares_owned_after_display":"11,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-08","scope":"insider"},{"id":8724124,"accession":"0000950170-23-021245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-021245","line_url":"/filing/0000950170-23-021245#line-1","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001916566","owner_name":"Tourangeau Greg","owner_display_name":"Tourangeau Greg","owner_url":"/insider/0001916566","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210.0,"shares_display":"210","price_per_share":3.31,"price_display":"3.31","price_state":"stated","total_value":695.1,"total_display":"695.10","total_whole":"695","shares_owned_after":15992.0,"shares_owned_after_display":"15,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001680581","name":"Fulcrum Therapeutics, Inc.","url":"/issuer/0001680581","role":"Officer (Principal Accounting Officer)","n_filings":4,"first_seen":"2023-05-11","last_seen":"2025-05-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001916566","retrieved_at":"2026-08-27T16:49:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}